In this age of budget cuts and health care reform it is becoming
increasingly important for each medical specialty to prove its value,
and back those assertions up with real data. It is not uncommon in these
discussions for emergency medicine to come under attack as cost-cutting
policies hone in on reducing ED visits for non-urgent care.
In her inaugural issue, we take a few minutes to learn a little bit about what makes this textbook author and world-renowned educator tick.
In 2001, Bernard et al published a piece in the New England Journal of
Medicine that changed the way physicians treated severe sepsis. PROWESS
asked whether, among patients with severe sepsis, activated protein C
might improve survival. The study was so successful, according to
researchers, that it was halted early.
A 31-year-old male was brought in by ambulance after attempting to hang
himself. He was found hanging from a tow rope in the back yard by his
brother who immediately cut him down. He was unconscious when he was cut
down and had been hanging for an unknown amount of time.
Boarding admitted patients in the ED is as bad for patient care as it is
for the hospital’s bottom line. So why aren’t more CEOs bringing this
pervasive problem to an end?
Never before have the cold, hard numbers behind emergency medicine been more accessible. Know how to access the data that will help your department anticipate new challenges.
EPM’s Ricardo Martinez sits down with healthcare economist Dr. Mark McClellan to discuss the future of medical homes and the evolving role of emergency medicine.
Emergency Physicians Monthly has teamed up with the board prep pros at Rosh Review to bring you a mini board review, so that you can test yourself on a regular basis and track your progress. The following is the test – and answers – from the June edition of Emergency Physicians Monthly. Questions about the test? Talk back on Twitter @epmonthly.
How many times have you evaluated acute, non-traumatic, monoarticular
arthritis while contemplating the risks and benefits of arthrocentesis
to rule-out septic arthritis? What about ruling-in a crystalloid
arthritis like gout?
Q: Does administering aspirin in the acute stages of ischemic stroke reduce death and disability?
Q: Does administration of thrombolytic agents for acute ischemic stroke patients reduce morbidity and mortality?